Literature DB >> 24640206

Comparison of seven Oxethazaine containing antacids available in the Indian market.

Suvarna Bhoir, A M Bhagwat.   

Abstract

OBJECTIVE: This in-vitro study was designed to measure the quantity of acid neutralized by a suspension of a commercial antacid available in Indian markets at a labeled dose and to test the concept of the relative effectiveness of 7 different commercial antacids containing Oxethazaine.
METHODS: A simple back titration methodology was used to determine the acid neutralization capacity (ANC) of antacids.
RESULTS: It was observed that different antacids vary widely in their in vitro ANC. There was also a batch to batch variation noted for each brand of antacid. The analysis indicated that there was a significant difference of ANC in favor of AD versus other antacids studied.
CONCLUSION: Comparison of relative effectiveness indicates that AD has highest ANC in vitro amongst other antacids. However, the present study being in vitro, the effects of antacid may vary in vivo, as individual variations also contribute to the ultimate effectiveness of an antacid.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24640206

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  1 in total

1.  Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A.

Authors:  Zhuo Bao; Ang Li; Xuebo Lu; Zitong Wang; Yin Yu; Wenjie Wu; Lili Zhao; Bo Li; Xiangyu Wu; Kyle Vaughn Laster; Chengjuan Zhang; Yanan Jiang; Zigang Dong; Kangdong Liu
Journal:  Cell Death Dis       Date:  2022-02-25       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.